发明名称 Composto, e, composição farmacêutica
摘要 <p>A compound represented by the general formula: or a pharmaceutically acceptable salt thereof or a solvate thereof, wherein Ring A is a C 6-14 aryl group or the like, L is -NR e CO- or the like (wherein R e is a hydrogen atom or the like), Ring B is a C 6-14 aryl group or the like, X is a C 1-3 alkylene group or the like, Y is a single bond or the like, Z is a C 1-3 alkylene group or the like, R 1 and R 2 are each independently a hydrogen atom or the like, and R 3 , R 4 , R 5 and R 6 are independently a hydrogen atom, a halogen atom or the like, has an A² production inhibitory effect or a BACE1 inhibitory effect and is useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by A² and typified by Alzheimer-type dementia.</p>
申请公布号 BRPI0906962(A2) 申请公布日期 2015.07.14
申请号 BR2009PI06962 申请日期 2009.01.16
申请人 EISAI R&D MANAGEMENT CO., LTD. 发明人 YUICHI SUZUKI;TAKAFUMI MOTOKI;TOSHIHIKO KANEKO;TOSHIHIKO KANEKO;TASUKU ISHIDA;KUNITOSHI TAKEDA;YOICHI KITA;NOBORU YAMAMOTO;AFZAL KAHN;PASCHALIS DIMOPOULOS
分类号 C07D279/08;A61K31/4439;A61K31/5415;A61K31/542;A61P25/28;A61P43/00;C07D417/10;C07D417/12;C07D513/04 主分类号 C07D279/08
代理机构 代理人
主权项
地址